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a Neurodegenerative Disease?A thought-provoking new study has found that symptom-free carriers of the
neurodegenerative Huntington’s disease present a dramatic two-fold
acceleration in perceptual learning.Pedro Cardoso-Leite1,
Philippe Ascher2,
and Daphne Bavelier1,3
The remarkable ease of learning seen
in children seems only a distant
memory to most of our adult brains.
Understanding the factors that might
renew such learning in older brains is
a main goal of brain plasticity studies.
A study published in this issue of
Current Biology [1] has opened new
possibilities by showing dramatically
improved learning in pre-symptomatic
Huntington’s disease carriers.
From Huntington’s Disease to Brain
Plasticity
Brain systems are shaped by
a complex interplay between genes
and experience, a process that begins
early in development and extends
throughout the life span. A major
determinant of such brain sculpting is
the balance between excitation and
inhibition in neural networks [2].
Excitatory-inhibitory co-tuning driven
by consistent and reliable patterned
sensory stimulation leads to the
progressive remodeling of the
receptive fields. Such sculpting of
connectivity through synaptic activity
eventually become associated with
a number of structural changes, which
in turn ultimately put a brake on further
exposure-based modifications [3]. By
adulthood, many of these brakes are in
place, limiting the potential brain
plasticity. This is why children typicallyrecover more gracefully from brain
insults than adults.
The recent work of Beste et al. [1]
aims to link increased excitation and
enhanced learning by focusing on
a special population of human
patients, those who carry the
Huntington disease (HD) gene, but
are not yet affected by its severe
dysregulation (termed pre-HD
thereafter). HD is a progressive
neurodegenerative disorder caused by
mutations of the Huntingtin gene that
confer toxic properties to the protein it
codes for. This results, among other
effects, in massive neural cell death
with up to 95% loss of GABAergic
medium spiny projection neurons in
the striatum, as well as atrophy in the
cerebral cortex and white matter. Key
symptoms include severe motor,
cognitive and psychiatric dysfunctions
that lead patients to lose their
autonomy at advanced stages of
the illness.
Despite intense research, HD
remains poorly understood and
incurable [4]. HD onset is declared
based on severe motor deficits. This
does not, however, imply that pre-HD
patients are unaffected by the disease.
In fact, pre-HD patients show
significant deficits in a broad range of
cognitive and emotional tasks when
carefully tested in a laboratory setting,
with deficiencies detectable as early as
15 years before disease onset [5].
These more subtle changes suggest
a dysregulation of the balance betweenexcitation and inhibition well before the
disease fully sets in.
Learning Capabilities of
Pre-symptomatic Huntington’s
Patients
To test the idea that pre-HD patients
may have enhanced learning
capabilities, Beste et al. [1] exploited
a new learning design they have
pioneered [6], testing perceptual
performance (Figure 1) before and after
a plasticity-inducing repetitive visual
stimulation ‘treatment’. The efficiency
of this ‘treatment’ is measured by
changes in perceptual performance
from pre- to post-treatment.
To induce plasticity, Beste et al. [1]
used an exposure-based learning
protocol, during which subjects are
presented sequences of rapidly (20 Hz)
alternating light and dark bars on the
computer screen for an extended
period of time. The temporal properties
of exposure-based learning resemble
those used to induce long-term
potentiation (LTP) and in this
perspective exposure-based learning
has been shown to produce plausible
behavioral learning effects [6].
The results of the experiments were
clear-cut. Before exposure-based
learning, pre-HD and control subjects’
perceptual performances were
identical. After 20 minutes of
exposure-based learning, pre-HD
patients largely outperformed control
subjects, for whom improvement is
absent after 20 minutes of
exposure-based learning but
progressively reaches pre-HD
performance level after 40 minutes
of exposure-based learning.
The comparison of specific groups
systematically yields suspicions of
sampling biases and the possibility of
confounding factors. Subjects who are
genetically tested for HD aremore likely
Time 
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Figure 1. Examples of the luminance detection task used to assess learning.
In a first 200 ms frame, subjects were shown two bars shortly followed by another 200 ms
display of two bars. Each bar had a set orientation (vertical or horizontal) and luminance
(lighter or darker than the background color). Across frames, the bars could differ either by
luminance, by orientation or by both. Participants were to report the location of luminance
changes when they occurred, ignoring the orientation change. Correct responses are shown
for each example trial. Increase in probability of detecting the luminance change provides
a measure of learning.
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R885to take antidepressants [7], some of
which might boost learning [8]. Pre-HD
subjects might be more motivated to
perform well and higher levels of
attention improve exposure-based
learning [9]. The presence of these
confounds, however, is unlikely. For
each pre-HD patient Beste et al. [1]
collected the ‘disease burden
score’ — an index of the Huntingtin
mutation strength — and found that
it correlated with learning-induced
performance improvement; pre-HD
patients with the highest disease
burden scores showed greater
learning.
These results are spectacular in the
face of the massive literature showing
subtle cognitive impairments in pre-HD
patients [5]. Their strength is such that
it may be worth considering the
inclusion of this experimental
setup — a fast, efficient and cheap
diagnostic tool — in the battery of tests
used to predict HD onset.
Molecular and Cellular Mechanisms
at Play
It has been repeatedly shown that
glutamate receptors, and in particular
NMDA receptors are involved in both
LTP and learning [10–13] as well as in
Huntington’s disease [14–16]. Mice in
which NR2B (a subtype of NMDA
receptor subunit) was overexpressed
in the forebrain show a stronger LTPand perform better in some learning
tasks [13]. Interestingly, these same
NR2B-containing receptors seem to be
responsible for altered NMDA receptor
function in various mouse models of
HD and overexpressing the NR2B
subunit in an HD model mouse
exacerbates selective striatal neuron
degeneration [14]. Overactivation of
NMDA receptors in HD could also be
increased by defective glutamate
uptake by astrocytes [17]. Finally,
memantine (a NMDA receptor blocker)
was shown in HD model mice to
reverse motor learning deficits,
confirming a role for NMDA receptor
[16]. Crucially, the exposure-based
learning treatment used here also
relies on NMDA receptors as
illustrated by the fact that memantine
impedes such learning in healthy
humans [18].
The evidence thus suggests that
an increased activation of NMDA
receptors in early HD might enhance
the degenerative process, increase
LTP and speed learning. This does not,
however, imply that in early HD
excitotoxicity is the cause of faster
learning, as hinted by the title of the
Beste et al. [1] paper. It is more likely
that increased NMDA receptor
activation is the common cause of
excitotoxicity and faster learning. That
NMDA receptors play an ‘ambivalent’
role with ‘good’ and ‘bad’ effects is welldocumented. Early attempts to block
excitotoxicity in stroke with NMDA
receptor antagonists quickly revealed
its risks for learning and memory [19].
This ambivalence was also found
when studying the ‘pro-death’ and
‘pro-survival’ signals mediated by
NMDA receptors in what has been
termed the ‘‘NMDA receptor paradox’’
[20]. Similarly, when HD develops,
overexpression or overactivation of
various forms of NMDA receptors may
lead to faster learning and to
neurodegeneration. But the fact that
these two effects are likely to occur in
parallel, rather than in sequence, leaves
some hope that the bad effects may be
selectively blocked. Adapting the
exposure-based learning procedure
pioneered in the present study to
animal models in future research could
be a productive way to characterize the
respective mechanisms subtending
enhanced learning and excitotoxicity in
Huntington’s disease.References
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